PC

Payel Chatterjee

Active Director Director DIN 08791812
DIN 08791812 First appointment Jul 2020 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Payel Chatterjee

Data last updated:

Payel Chatterjee is a Director at Osto Genetica Pharmaceuticals Private Limited (since 2020). The company operates in Healthcare.

DIN 08791812
Primary Designation Director
Industry Healthcare
First Appointment 08 Jul 2020
Oldest Company Age 10 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director08 Jul 20202016Active

Board colleagues of Payel Chatterjee

Directorship timeline

Open interactive timeline →
Osto Genetica Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Payel Chatterjee

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Payel Chatterjee

Payel Chatterjee currently holds 1 directorship: Osto Genetica Pharmaceuticals Private Limited (Director, since 08 Jul 2020).

Payel Chatterjee was first appointed on 08 Jul 2020 as Director at Osto Genetica Pharmaceuticals Private Limited.

The current boards of Payel Chatterjee's companies include Komal Rajat Rastogi (Osto Genetica Pharmaceuticals Private Limited), Phool Sharma (Osto Genetica Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available